Pliant Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
41.91
|
|
Average Rating
|
4.58
|
|
# Strong Buys
|
7
|
|
# Buys
|
5
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.74
|
-0.65
|
0.09
|
12.16%
|
|
2022-06-30
|
-0.81
|
-0.82
|
-0.01
|
-1.23%
|
|
2022-03-31
|
-0.75
|
-0.78
|
-0.03
|
-4.00%
|
|
2021-12-31
|
-0.76
|
-0.68
|
0.08
|
10.53%
|
|
2021-09-30
|
-0.69
|
-0.75
|
-0.06
|
-8.70%
|
|
2021-06-30
|
-0.67
|
-0.64
|
0.03
|
4.48%
|
|
2021-03-31
|
-0.60
|
-0.64
|
-0.04
|
-6.67%
|
|
2020-12-31
|
-0.71
|
-0.54
|
0.17
|
23.94%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.25
|
|
2021-12-31
|
-2.71
|
|
2020-12-31
|
-3.05
|